标题
Recent advances in the management of pulmonary sarcomatoid carcinoma
作者
关键词
-
出版物
Expert Review of Respiratory Medicine
Volume 10, Issue 4, Pages 407-416
出版商
Informa UK Limited
发表日期
2016-03-11
DOI
10.1586/17476348.2016.1157475
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma
- (2016) Yongbin Lin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
- (2016) J. H. Tong et al. CLINICAL CANCER RESEARCH
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations
- (2016) Xuewen Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
- (2015) V. Fallet et al. ANNALS OF ONCOLOGY
- Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
- (2015) Sehui Kim et al. EUROPEAN JOURNAL OF CANCER
- MET 14 Deletion in Sarcomatoid Non-Small-Cell Lung Cancer Detected by Next-Generation Sequencing and Successfully Treated with a MET Inhibitor
- (2015) Carrie Lee et al. Journal of Thoracic Oncology
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
- (2015) P. K. Paik et al. Cancer Discovery
- Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
- (2015) G. M. Frampton et al. Cancer Discovery
- MET As a Possible Target for Non–Small-Cell Lung Cancer
- (2013) Ahad A. Sadiq et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
- (2013) Thibault Vieira et al. Journal of Thoracic Oncology
- The Value of Biomarkers in Patients With Sarcomatoid Carcinoma of the Lung: Molecular Analysis of 33 Cases
- (2012) Xiangli Jiang et al. Clinical Lung Cancer
- Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung
- (2012) Jamie E. Chaft et al. Journal of Thoracic Oncology
- Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene
- (2012) Giuseppe Pelosi et al. LUNG CANCER
- Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis
- (2012) Sai Yendamuri et al. SURGERY
- Evaluation of Six Patients with Pulmonary Carcinosarcoma with a Literature Review
- (2012) Sinem Nedime Sökücü et al. TheScientificWorldJOURNAL
- EGFR and p53 Status of Pulmonary Pleomorphic Carcinoma: Implications for EGFR Tyrosine Kinase Inhibitors Therapy of an Aggressive Lung Malignancy
- (2011) Yih-Leong Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Clinicopathologic Outcomes of Curative Resection for Sarcomatoid Carcinoma of the Lung
- (2011) Joon Suk Park et al. ONCOLOGY
- Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis
- (2010) Kyoichi Kaira et al. Journal of Thoracic Oncology
- EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy
- (2009) Antoine Italiano et al. INTERNATIONAL JOURNAL OF CANCER
- Review Article: Pulmonary Sarcomatoid Carcinomas: A Practical Overview
- (2009) Giuseppe Pelosi et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Genetic Heterogeneity of EGFR Mutation in Pleomorphic Carcinoma of the Lung: Response to Gefitinib and Clinical Outcome
- (2009) A. Ushiki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinical characteristics of pleomorphic carcinoma of the lung
- (2009) Kenichiro Ito et al. LUNG CANCER
- Pleomorphic Carcinoma of the Lung
- (2008) Takahiro Mochizuki et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma
- (2008) Jung Yong Hong et al. MEDICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now